Communiqués ResMed Inc. Australian S.E.

Actions

RMD

AU000000RMD6

Equipement et technologie médicale avancés

Marché Fermé - Australian S.E. 08:17:25 03/09/2026			Varia. 5j.	Varia. 1 janv.
32,09 ^AUD	-0,59%		-0,65%	-10,71%

03/09	ResMed, Inc. : Morgan Stanley est neutre	ZM
02/09	ResMed conclut un accord de rachat d'actions accéléré de 450 millions de dollars avec Citibank ; le titre recule de 3%	MT

Communiqués

02/09	Frazier Healthcare Partners Completes Acquisition of MatrixCare, Appoints Jonathan Lujan as Chief Executive Officer	AQ
27/08	Resmed Announces Participation in the 24th Annual Morgan Stanley Global Healthcare Conference	GL
25/08	23XI Racing NASCAR Driver Tyler Reddick Reveals Sleep Apnea Diagnosis, Teams Up with Resmed to Help Others Recognize the Signs	GL
17/08	Resmed Announces Appointment of Carol Burt as Lead Director and Planned Retirement of Director Ron Taylor	GL
06/08	ResMed: Fiscal Q4 Earnings Snapshot	AQ
06/08	Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2026	GL
06/08	Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2026	AQ
24/07	Catapult Sports, Hazer Group & ResMed	AQ
21/07	BetterInvesting™ Magazine Update on Broadridge Financial Resources Inc. (NYSE:BR) and ResMed Inc. (NYSE:RMD)	PR
07/07	Resmed Announces Agreement to Sell MatrixCare Business	GL
30/06	Resmed to Report Fourth Quarter Fiscal 2026 Earnings on August 6, 2026	GL
11/06	Resmed at SLEEP 2026: Advancing Sleep Health Through Innovation in Screening, Diagnosis and Personalized Care	PU
01/06	Resmed Completes Acquisition of Noctrix Health, Expanding Clinical Sleep Health Portfolio	GL
19/05	Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference	GL
19/05	Resmed and ŌURA Partner to Expand Access to Sleep Health Education and Care	GL
19/05	Resmed and ŌURA Partner to Expand Access to Sleep Health Education and Care	AQ
02/05	ResMed : Earnings Webcast Q3 2026 Transcript PDF	PU
01/05	ResMed : 3Q26 Earnings Presentation	PU
01/05	Resmed : Chief Financial Officer Brett Sandercock to Retire; Aaron Bloomer Appointed as Successor	PU
30/04	ResMed: Fiscal Q3 Earnings Snapshot	AQ
30/04	Resmed Chief Financial Officer Brett Sandercock to Retire; Aaron Bloomer Appointed as Successor	GL
30/04	Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2026	GL
30/04	Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2026	AQ
01/04	Resmed to Report Third Quarter Fiscal 2026 Earnings on April 30, 2026	GL
04/03	Resmed's Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains out of Reach	AQ